SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-084289
Filing Date
2023-07-26
Accepted
2023-07-26 16:06:14
Documents
13
Period of Report
2023-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2322054d1_8k.htm   iXBRL 8-K 28176
  Complete submission text file 0001104659-23-084289.txt   250460

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vacc-20230720.xsd EX-101.SCH 3545
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vacc-20230720_def.xml EX-101.DEF 26916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vacc-20230720_lab.xml EX-101.LAB 36969
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vacc-20230720_pre.xml EX-101.PRE 25540
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2322054d1_8k_htm.xml XML 4995
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Vaccitech plc (Filer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 231113545
SIC: 2834 Pharmaceutical Preparations